OverviewChartNewsTraderScreen

Emisphere Technologies/  US2913451066  /

Nasdaq Other OTC
12/8/2020  12:00:00 AM Chg. - Volume Bid- Ask- High Low
7.8100USD - 184,515
Turnover: -		 -Bid Size: - -Ask Size: - 7.8200 7.8000
GlobeNewswire 12/8/2020 Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion
GlobeNewswire 12/1/2020 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, an...
GlobeNewswire 11/20/2020 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, LBRT, TNAV, an...
GlobeNewswire 11/12/2020 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Emisphere Technologies, Inc. Bu...
GlobeNewswire 11/10/2020 Emisphere Technologies, Inc. (OTC:EMIS) INVESTOR NOTICE: Abraham, Fruchter & Twersky, LLP Is Investi...
GlobeNewswire 11/9/2020 EMISPHERE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EMIS and Encourages Investors to C...
GlobeNewswire 11/6/2020 Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion
TeleTrader 11/6/2020 Novo Nordisk buying Emisphere Tech for $1.8B
GlobeNewswire 7/14/2020 Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors
GlobeNewswire 4/6/2020 EMISPHERE DEVELOPMENT UPDATE
GlobeNewswire 11/18/2019 RenovaCare Appoints Alan L. Rubino as President and CEO
GlobeNewswire 10/1/2019 Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
GlobeNewswire 9/20/2019 Emisphere Development Update
GlobeNewswire 9/10/2019 Emisphere Announces Leadership Changes
GlobeNewswire 4/26/2019 Emisphere Development Update
GlobeNewswire 3/20/2019 Emisphere Development Update
GlobeNewswire 8/28/2018 Emisphere’s Proprietary Eligen Technology Supports Novo Nordisk’s Oral Semaglutide
GlobeNewswire 6/29/2018 Emisphere Development Update
GlobeNewswire 6/21/2018 Emisphere Development Update
GlobeNewswire 6/21/2018 Bioavailability Enhancement Technologies and Services Market, 2030
GlobeNewswire 5/31/2018 Emisphere Development Update
GlobeNewswire 5/30/2018 ELIGEN B12 Receives “Amazon’s Choice” Designation
GlobeNewswire 5/16/2018 Oral Proteins and Peptides Market, 2030
GlobeNewswire 4/26/2018 Emisphere Amends License Agreement with Novo Nordisk
GlobeNewswire 3/1/2018 Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors